"Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of 50%: The EMPOWER-Lung 1 study"(vol 129, pg 118, 2023)M. Gumus,C- Chen,C. IvanescuCANCER（2024）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
